KENTUCKY — Booster doses of the COVID-19 vaccine can now be taken by all Kentucky adults. Gov. Beshear on Wednesday signed an executive order qualifying more Kentuckians for the vaccine booster as statewide numbers show new cases are appearing to plateau.


What You Need To Know

  • Gov. Andy Beshear has authorized COVID-19 vaccine boosters for all Kentucky adults

  • Beshear signed an executive order Wednesday making it official

  • New COVID-19 cases appear to be plateauing after seven weeks of consistent decline, Beshear said

  • The move comes as more and more states are expanding eligibility for booster shots, going beyond the FDA's recommendations and authorizations

The executive order qualifies those aged 18 and up to get a COVID-19 vaccination booster six months after their second dose of the Moderna or Pfizer COVID-19 vaccines, or two months after a single-dose Johnson & Johnson COVID-19 vaccine.

Those receiving the booster must live or work in the Commonwealth, the order said.

COVID-19 booster shots can be administered at Walgreens, CVS, Kroger and Walmart locations, in addition to hospitals, primary care physicians and other health care facilities. If you need to find a booster appointment, click here.

After seven weeks of decline in new cases and the test positivity rate, Gov. Beshear said cases "appear to be hitting a plateau," according to the latest state health data.

A growing number of states, as well as New York City, have expanded eligibility for COVID-19 vaccine booster shots in recent days, going beyond the Food and Drug Administration’s authorization.

The FDA has granted emergency use authorization for the Pfizer and Moderna boosters for people who are 65 or older, who have underlying medical conditions, or who work or live in high-risk settings, such as prisons or homeless shelters. The Johnson & Johnson boosters, however, are authorized for all adults.

The Centers for Disease Control and Prevention recommends boosters for the same groups covered by the FDA authorizations.

But with winter approaching and COVID-19 cases climbing again, some state and local governments are applying a broad interpretation to the FDA authorization and CDC guidance.